InMed Pharmaceuticals Inc

INMNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

5.34M

on 2026-06-30, from 317K on 2024-03-31 10-K ↗

Earlier counts are adjusted for the 1-for-20 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$50.0M

S-3 of 2026-03-20. 1 prospectus supplement filed under it since. S-3 ↗

$1.2M

H.C. Wainwright, agreement of 2026-04-03. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

544K

Priced warrants: 544K at $21.20, 2026-06-30. 10-K ↗

Cash

1 quarters

$2.2M on 2026-06-30 ÷ $2.2M a quarter of operating cash used, the average of four quarters. 10-K ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-06-24	Private placement	not read	$2.561	not stated	8-K ↗

Also on file: a going-concern note in the 10-K filed 2026-09-09 10-K ↗